XML 37 R25.htm IDEA: XBRL DOCUMENT v3.21.2
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Sales Revenue by Similar Products (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Sep. 11, 2021
Sep. 12, 2020
Sep. 11, 2021
Sep. 12, 2020
Concentration Risk [Line Items]        
Net sales and other revenue $ 16,505.7 $ 15,757.6 $ 37,775.1 $ 38,509.2
Product Line | Product Concentration Risk        
Concentration Risk [Line Items]        
Net sales and other revenue $ 16,505.7 $ 15,757.6 $ 37,775.1 $ 38,509.2
Percentage of total net sales and other revenue 100.00% 100.00% 100.00% 100.00%
Non-perishables | Product Line | Product Concentration Risk        
Concentration Risk [Line Items]        
Net sales and other revenue $ 7,268.5 $ 7,126.6 $ 16,538.8 $ 17,910.4
Percentage of total net sales and other revenue 44.00% 45.20% 43.80% 46.50%
Perishables | Product Line | Product Concentration Risk        
Concentration Risk [Line Items]        
Net sales and other revenue $ 6,823.2 $ 6,654.1 $ 15,735.8 $ 16,209.7
Percentage of total net sales and other revenue 41.30% 42.20% 41.60% 42.10%
Pharmacy | Product Line | Product Concentration Risk        
Concentration Risk [Line Items]        
Net sales and other revenue $ 1,253.4 $ 1,171.8 $ 2,982.0 $ 2,726.7
Percentage of total net sales and other revenue 7.60% 7.50% 7.90% 7.10%
Fuel | Product Line | Product Concentration Risk        
Concentration Risk [Line Items]        
Net sales and other revenue $ 918.5 $ 570.8 $ 1,967.8 $ 1,160.0
Percentage of total net sales and other revenue 5.60% 3.60% 5.20% 3.00%
Other | Product Line | Product Concentration Risk        
Concentration Risk [Line Items]        
Net sales and other revenue $ 242.1 $ 234.3 $ 550.7 $ 502.4
Percentage of total net sales and other revenue 1.50% 1.50% 1.50% 1.30%